CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis

Overview of attention for article published in PLOS ONE, January 2010

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 7 patents

f1000: 1 research highlight platform

Citations

dimensions_citation: 169 Dimensions

Readers on

mendeley: 78 Mendeley

Summary Patents Research highlights Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis

Grant US-11725056-B2

United States of America

Methods for reducing severity of pulmonary fibrosis

Grant US-10973882-B2

United States of America

Method effective to modulate expression of T-box protein 4 (Tbx4) for reducing…

Grant US-10973842-B2

United States of America

Biomarkers for assessing idiopathic pulmonary fibrosis

Grant US-10961582-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.